Literature DB >> 23994587

Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.

Wahid Boukouaci1, Reem Al-Daccak, Nicolas Dulphy, Laura Lauden, Kahina Amokrane, Catherine Fortier, François Marzais, Meriem Bennabi, Regis Peffault de Latour, Gerard Socie, Antoine Toubert, Dominique Charron, Rajagopal Krishnamoorthy, Ryad Tamouza.   

Abstract

A soluble isoform of MHC class I chain-related molecule A (soluble MICA), generated by proteolytic shedding from the membrane-bound MICA of various tumor cells, has been shown to downregulate both the expression of natural killer group 2-member D receptor and the cytotoxic function of effectors cells and was postulated as a mechanism for tumor immune evasion. Its effect on the expression of cytokines by the effector cells remained unexplored. Here we demonstrate that the sMICA molecules upregulate interferon gamma expression by interleukin-12/interleukin-18-activated CD3(-)CD56(+) natural killer cells, witnessing the pro-inflammatory effect of soluble MICA. Overall, these data are in line with our previous observations that the raised serum levels of soluble MICA, following allogeneic hematopoietic stem cell transplantation, confer susceptibility to and the presence of pre-transplantation anti-MICA antibodies in the patient's serum confer protection against chronic graft versus host disease.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  IFN-γ; IL; MHC class I chain-related molecule A; MICA; NK; NKG2D; allo-HSCT; allogeneic hematopoietic stem cell transplantation; cGvHD; chronic graft versus host disease; interferon gamma; interleukin; mbMICA; membrane-bound MICA; natural killer; natural killer group 2-member D; sMICA; soluble MICA

Mesh:

Substances:

Year:  2013        PMID: 23994587     DOI: 10.1016/j.humimm.2013.08.281

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration.

Authors:  Kasper Vadstrup; Elisabeth Douglas Galsgaard; Helle Jensen; Lewis L Lanier; James C Ryan; Shih-Yu Chen; Garry P Nolan; Marianne Kajbæk Vester-Andersen; Julie Steen Pedersen; Jens Gerwien; Teis Jensen; Flemming Bendtsen
Journal:  Exp Mol Pathol       Date:  2017-07-03       Impact factor: 3.362

Review 2.  MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?

Authors:  Matilde Risti; Maria da Graça Bicalho
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

3.  Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.

Authors:  John P Veluchamy; María Delso-Vallejo; Nina Kok; Fenna Bohme; Ruth Seggewiss-Bernhardt; Hans J van der Vliet; Tanja D de Gruijl; Volker Huppert; Jan Spanholtz
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

Review 4.  Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.

Authors:  Raphael Carapito; Ismail Aouadi; Wassila Ilias; Seiamak Bahram
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

Review 5.  Anti-NKG2D mAb: A New Treatment for Crohn's Disease?

Authors:  Kasper Vadstrup; Flemming Bendtsen
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

6.  Impact of microRNA-29b on natural killer cells in T-cell acute lymphoblastic leukemia.

Authors:  Fengyan Jin; Zhonghua Du; Yang Tang; Lixia Wang; Yanping Yang
Journal:  Oncol Lett       Date:  2019-07-04       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.